Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Interventions

pembrolizumab 41 Injections 39 toripalimab 23 Nivolumab 22 Cisplatin 19 Pemetrexed 18 Carboplatin 18 Cyclophosphamide 17 Paclitaxel 14 Bevacizumab 14 fludarabine 12 Gemcitabine 11 tislelizumab 10 Ipilimumab 10 spartalizumab 9 Irinotecan 9 atezolizumab 8 Docetaxel 8 Oxaliplatin 7 Leucovorin 7 Fluorouracil 7 Capecitabine 6 sintilimab 5 Interleukin-2 5 Albumin-Bound Paclitaxel 5 130-nm albumin-bound paclitaxel 5 trifluridine tipiracil drug combination 4 sotorasib 4 pazopanib 4 palbociclib 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × ODM-207 × Other solid neoplasm × Clear all

NCT03035591 2019-10-15

BETIDES

Orion Corporation, Orion Pharma

Phase 1/2 Completed

Other solid neoplasm

Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡